Teprotumumab for Active Thyroid Eye Disease

被引：0

作者：

Roos, Jonathan C. P. ^{[1
]}

Hyry, Hanna I. ^{[2
]}

Murthy, Rachna ^{[3
]}

机构：

[1] Moorfields Eye Hosp, London, England

[2] Univ Cambridge, Cambridge, England

[3] Cambridge Univ Hosp, Cambridge, England

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1959 / 1959

页数：1

共 3 条

[1] Outrageous prices of orphan drugs: a call for collaboration
Luzzatto, Lucio
Hyry, Hanna I.
Schieppati, Arrigo
Costa, Enrico
Simoens, Steven
Schaefer, Franz
Roos, Jonathan C. P.
Merlini, Giampaolo
Kaariainen, Helena
Garattini, Silvio
Hollak, Carla E.
Remuzzi, Giuseppe
[J]. LANCET, 2018, 392 (10149) : 791 - 794
[2] Update on the clinical assessment and management of thyroid eye disease
Roos, Jonathan C. P.
Murthy, Rachna
[J]. CURRENT OPINION IN OPHTHALMOLOGY, 2019, 30 (05) : 401 - 406
[3] Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves' orbitopathy
Roos, Jonathan C. P.
Murthy, Rachna
[J]. EYE, 2019, 33 (04) : 679 - 682